PAHC:NAS (USA) Also trade in: Germany

Phibro Animal Health Corp

$ 33.09 -0.28 (-0.84%)
Volume: 93,949 Avg Vol (1m): 143,314
Market Cap $: 1.34 Bil Enterprise Value $: 1.58 Bil
P/E (TTM): 18.51 P/B: 6.52
Earnings Power Value 18.5
Net Current Asset Value -1.26
Tangible Book 3.15
Projected FCF 10.41
Median P/S Value 34.19
Graham Number 11.27
Peter Lynch Value 14.98
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 6/10

Current vs industry vs history
Cash-to-Debt 0.25
Equity-to-Asset 0.29
Debt-to-Equity 1.58
Debt-to-EBITDA 2.47
Interest Coverage 7.65
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.18
DISTRESS
GREY
SAFE
Beneish M-Score -2.31
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 18.99%
WACC 2.76%

Profitability & Growth : 5/10

Current vs industry vs history
Operating Margin % 12.06
Net Margin % 8.70
ROE % 39.00
ROA % 10.80
ROC (Joel Greenblatt) % 29.77
3-Year Total Revenue Growth Rate 3.10
3-Year Total EBITDA Growth Rate 3.80
3-Year EPS w/o NRI Growth Rate 2.20

» PAHC's 30-Y Financials

Financials (Next Earnings Date: 2019-05-06)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:PAHC

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Drug Manufacturers » Drug Manufacturers - Specialty & Generic    NAICS : 311119    SIC : 742
Compare HKSE:02877 TSE:8129 NAS:OPK NYSE:DPLO NAS:AKRX SHSE:603567 NAS:MNTA BOM:540596 SZSE:300630 TSE:4555 BOM:532872 SHSE:600329 TSX:LEAF SZSE:300401 XKRX:145020 BOM:533573 XKRX:003520 XKRX:041960 TSE:4569 NAS:RDUS
Traded in other countries PB8.Germany
Address 300 Frank West Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Ratios

Current vs industry vs history
PE Ratio (TTM) 18.51
Forward PE Ratio 18.21
N/A
PE Ratio without NRI 18.51
Price-to-Owner-Earnings 51.48
PB Ratio 6.52
PS Ratio 1.56
Price-to-Free-Cash-Flow 48.30
Price-to-Operating-Cash-Flow 26.98
EV-to-EBIT 15.25
EV-to-EBITDA 12.10
EV-to-Revenue 1.85
PEG Ratio 2.07
Current Ratio 3.25
Quick Ratio 1.83
Days Inventory 117.61
Days Sales Outstanding 62.66
Days Payable 41.83

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 1.33
Dividend Payout Ratio 0.23
Forward Dividend Yield % 1.44
N/A
Yield-on-Cost (5-Year) % 1.33
3-Year Share Buyback Rate -1.10

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 10.50
Price-to-Projected-FCF 3.18
Price-to-Median-PS-Value 0.97
Price-to-Peter-Lynch-Fair-Value 2.21
Price-to-Graham-Number 2.94
Earnings Yield (Joel Greenblatt) % 6.53
Forward Rate of Return (Yacktman) % 10.76

More Statistics

Revenue (TTM) (Mil) $ 839.07
EPS (TTM) $ 1.79
Beta 0.01
Volatility % 30.47
52-Week Range $ 28.29 - 54.62
Shares Outstanding (Mil) 40.45

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA N
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N